Pekin Hardy Strauss’s Starling Oncology STLN Stock Holding History
Bought
Maintained
Sold
Other funds holding STLN
JAIC
Pekin Hardy Strauss's STLN Position: Q3 2026 in Review
Pekin Hardy Strauss reduced its Starling Oncology (STLN) stake by 44% in Q3 2026, selling an estimated $83.7K and leaving 18,000 shares worth $114K. The position accounts for 0.01% of the portfolio, ranked #465.
Pekin Hardy Strauss first reported a position in STLN in Q4 2025 and has held it in 4 quarters since. The position peaked at $174K in Q2 2026. 131 funds tracked by Wall St. Rank hold STLN as of Q3 2026.
- Pekin Hardy Strauss held 18,000 shares of Starling Oncology worth $114K as of Q3 2026.
- Pekin Hardy Strauss sold 14,000 Starling Oncology shares in Q3 2026, an estimated $83.7K.
- Starling Oncology made up 0.01% of Pekin Hardy Strauss's portfolio in Q3 2026, its #465 holding.
- Pekin Hardy Strauss first reported a position in Starling Oncology in Q4 2025 and has held it in 4 quarters since.
- Pekin Hardy Strauss's Starling Oncology position peaked at $174K in Q2 2026.
- 131 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.
Based on Pekin Hardy Strauss's 13F filing for Q3 2026, filed 2 Nov 2026.